JAMES R. KASINGER Insider Trading $CRSP CRISPR Therapeutics AG
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES R. KASINGER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES R. KASINGER. JAMES R. KASINGER is General Counsel and Secretary in CRISPR Therapeutics AG ($CRSP).
JAMES R. KASINGER in CRISPR Therapeutics AG
Trading Symbol: CRSPIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JAMES R. KASINGER: General Counsel and Secretary
Holdings: 25,264 shares
Current Value: $397,908
Latest Transaction: Mar 12 2021
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JAMES R. KASINGER in CRISPR Therapeutics AG
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
Mar 12 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | A | 133.88 | 25,360 | 3,395,197 | 25,360 | |
Mar 12 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Payment of Exercise | F | 124.15 | 1,353 | 167,975 | 23,911 | 25.3 K to 23.9 K (-5.36 %) |
Mar 12 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Buy | M | 0.00 | 2,833 | 0 | 25,264 | 22.4 K to 25.3 K (+12.63 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | M | 51.49 | 27,500 | 1,415,975 | 12,500 | |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Sell | S | 207.61 | 2,100 | 435,981 | 22,431 | 24.5 K to 22.4 K (-8.56 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Sell | S | 206.05 | 1,800 | 370,890 | 24,531 | 26.3 K to 24.5 K (-6.84 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Sell | S | 205.60 | 8,997 | 1,849,783 | 26,331 | 35.3 K to 26.3 K (-25.47 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Sell | S | 204.40 | 7,818 | 1,597,999 | 35,328 | 43.1 K to 35.3 K (-18.12 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Sell | S | 203.58 | 6,785 | 1,381,290 | 43,146 | 49.9 K to 43.1 K (-13.59 %) |
Jan 20 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Buy | M | 51.49 | 27,500 | 1,415,975 | 49,931 | 22.4 K to 49.9 K (+122.60 %) |
Dec 10 2020 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | M | 13.62 | 22,026 | 299,994 | 100,974 | |
Dec 10 2020 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Buy | M | 13.62 | 22,026 | 299,994 | 22,415 | 389 to 22.4 K (+5,662.21 %) |
Oct 06 2020 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | A | 86.75 | 11,666 | 1,012,026 | 11,666 | |
Dec 05 2019 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Sep 12 2019 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Mar 07 2019 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | A | 40.87 | 65,000 | 2,656,550 | 65,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | A | 59.31 | 32,000 | 1,897,920 | 32,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | A | 59.31 | 32,000 | 1,897,920 | 32,000 | |
Mar 09 2018 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | A | 51.49 | 40,000 | 2,059,600 | 40,000 |
Page: 1